# Advisor Review - GPT-5.2

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.2
**Paper:** paper.pdf
**Timestamp:** 2026-03-05T15:45:32.710586
**Route:** OpenRouter + LaTeX
**Paper Hash:** 30172e8ec01105fc
**Tokens:** 17231 in / 1242 out
**Response SHA256:** f50ad14733f4f968

---

No fatal errors found in the four categories you specified.

### 1) Data–Design Alignment (critical)
- **Treatment timing vs. data coverage:** Treatment is dated to **2024Q1** (first tax year) with an alternative timing of **2023Q3** (decree publication). Estimation sample covers **2020Q1–2024Q4**, so treatment and post periods are within data support.
- **Post-treatment observations:** With treatment at 2024Q1 and sample ending 2024Q4, you have **4 post-treatment quarters** for the newly treated cohort. Event-study description also remains consistent with available post periods.
- **Treatment definition consistency:** Treatment variable is consistently defined as “newly treated × (t ≥ 2024Q1)” in the main DiD; alternative timing is explicitly labeled and separately reported.

### 2) Regression Sanity (critical)
Checked all reported regression tables for obvious numerical/pathological issues:
- **Standard errors** are all in plausible ranges relative to coefficients (no extreme SEs, no SEs vastly exceeding coefficients by 100×, no negative SEs).
- **Coefficients** are plausible for log outcomes (magnitudes small; none remotely near thresholds like 10 or 100).
- **Impossible values:** No R² values are reported (so none can be invalid); no NA/NaN/Inf shown in any table entries.

### 3) Completeness (critical)
- All regression tables shown include **standard errors** and **sample sizes (Observations)**.
- No visible placeholders like **TBD / TODO / NA** in tables.
- All in-text references to numbered tables/figures appear to correspond to existing LaTeX `\label{}` objects in the source you provided (I cannot verify external PDF figure files exist on disk, but within the LaTeX source there are no missing figure/table environments being referenced).

### 4) Internal Consistency (critical)
- The key sample-size arithmetic is consistent:
  - Newly treated + never treated communes = 2,496 + 29,405 = **31,901**, matching Table 2.
  - 31,901 communes × 20 quarters = **638,020 observations**, matching Table 2.
- Treatment/post timing is consistent across the main specification, event study (reference period 2023Q4; treatment 2024Q1), and robustness table.

ADVISOR VERDICT: PASS